Cell Lines

MG Milos Gojkovic
PC Pedro P. Cunha
GD Gabriella S. Darmasaputra
LB Laura Barbieri
HR Helene Rundqvist
PV Pedro Veliça
RJ Randall S. Johnson
request Request a Protocol
ask Ask a question
Favorite

All tumor cell lines were cultured in DMEM (11995065, Gibco) supplemented with 10% FBS (10270106, Gibco) and 1% penicillin/streptomycin (10378016, Gibco).

B16-F10-OVA were generated through co-transfection of the transposon vector pT2 containing codon-optimized genes for chicken ovalbumin (OVA; P01012.2), eGFP (ABG78037.1), neomycin phosphotransferase (NeoR; BAD00047.1) and the vector encoding transposase SB11.

OVA, eGFP and NeoR were expressed as a polycistronic peptide interspersed with P2A and furin cleavage sites and synthesized by Gene Art (Thermo Fisher). This was then cloned under the promoter SV40 in the transposon vector pT27BH (gift from Perry Hackett, Addgene plasmid #26556). Plasmid containg the sleeping beauty transposase (pCMV-SB11, Addgene plasmid #26552) was a gift from Perry Hackett.

Transfected cells were cultured with 400 mg/mL G418 (10131027, Gibco) three days post transfection in order to select for transfected cells. Transfection success was confirmed through flowcytometry analysis of eGFP fluorescence. Clonal B16-F10-OVA cell line was then produced through limiting dilution.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A